Prediction Case File
YouTubeTracking Live

Why Insiders Are Loading Up on Oracle Stock

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
17 Oct 2026, 17:09 UTC
Recorded by Tahlil Plus
17 Oct 2026, 20:30 UTC
Video preview for Why Insiders Are Loading Up on Oracle Stock
Source overview

AI-generated source summary

Oracle Corp (ORCL) currently trades at $128.23. The analysis suggests a significant upside potential based on a scenario analysis of future cash flows. By assuming different cash flow multiples (20x, 25x, and 30x) applied to a projected $50 billion cash flow by 2031, the market cap could reach $1.00T, $1.25T, or $1.50T respectively. This translates to potential share prices of $333, $417, or $500 in 2031. The analysis is based on TD Cowen's report projecting OCI gross profit to reach $88.8B and OCI gross margin to be 42% by FY31E, with free cash flow turning positive. The company has substantial cash reserves ($37B) and net cash ($20B) to manage its debt obligations, which are spread out and do not pose an immediate risk. Despite current negative free cash flow and a recent credit rating downgrade to BBB-/A-3 by S&P, the fundamental outlook remains positive due to growth in cloud infrastructure and applications, with future cash flow expected to cover debt and fuel further growth. The downside risk is limited as significant debt payments are deferred until after 2031.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
359
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail